3.900
+0,00%
2026-10-19
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +2.3% | +44.2% | 2 / 3 | -4.0% | -2.45 pp | +0.10 pp | +2.7% | 0.14 | 11.98 | 473 | −4,0% | 7,5 | +2,3% | 11.98 | 12.82 | −6,6% |
| Pts | 0 | 8 | 8 | 0 | 4 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 3.900 (close price on 2026-10-19)EPS (TTM): 325,6
Financial charts
1.Revenue & growth
VND bn473Q2/26
1.Revenue & growth
VND bn473Q2/26
2.Profit & growth
VND bn7,52Q2/26
3.Profit mix (Penman)
VND bn23,4Q2/26
4.Margins & cost structure
%14.8%Q2/26
5.Returns & cash cycle
% · days2.9%Q2/26
6.Earnings quality & cash
VND bn185Q2/26
7.Asset structure
VND bn1.417Q2/26
8.Funding & debt health
VND bn · times1.417Q2/26
9.Revenue backlog
VND bn0,77Q2/26
10.Valuation
times · %12,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %101Q2/26
Adjusted EPS growth, latest quarter
2.3%
Average adjusted EPS growth, 3 quarters
-3.2%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26